In a significant advancement for emergency care, Jharkhand's health department is introducing life-saving enoxaparin injections in district and medical college hospitals that do not have cardiology ...
Zacks Investment Research on MSN
CRMD up more than 40% YTD: Time to buy, sell or hold the stock?
Shares of CorMedix CRMD have witnessed a strong surge so far this year, primarily driven by the continued strong uptake of ...
Upcoming product launches -- AMP-007 inhalation on track for mid-2026 launch targeting a $1.5 billion market; generic teriparatide (AMP-015) in first half of 2026; AMP-018 (GLP-1) and insulin aspart ...
Zacks Investment Research on MSN
Can DefenCath continue to aid CorMedix's long-term growth ahead?
CorMedix’s CRMD lead therapy, DefenCath (taurolidine + heparin), is currently the company’s majority revenue driver. The FDA ...
Unapproved peptide drugs have become a trendy new hack among wellness influencers, fitness coaches and celebrities, pitched as a way to build muscle, shed pounds and look younger. Online stores will ...
Aimovig is a brand-name medication that is prescribed to prevent migraine episodes in adults. It is administered via injection, not for treating symptoms as they occur. Common side effects of Aimovig ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback